title: A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry.
authors.affiliation: Chair and Department of Hematology, Jagiellonian University Medical College, Kraków, Poland.
authors.forename: Tomasz
authors.identifier: http://orcid.org/0000-0002-7207-6595
authors.initials: T
authors.lastname: Sacha
authors.affiliation: Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
authors.forename: Joanna
authors.initials: J
authors.lastname: Góra-Tybor
authors.affiliation: Department of Hematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland.
authors.forename: Monika
authors.initials: M
authors.lastname: Szarejko
authors.affiliation: Hematology and Bone Marrow Transplantation Department, Medical Silesian University, Katowice, Poland.
authors.forename: Grażyna
authors.initials: G
authors.lastname: Bober
authors.affiliation: Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland.
authors.forename: Olga
authors.initials: O
authors.lastname: Grzybowska-Izydorczyk
authors.affiliation: Hematology, Oncology, and Internal Medicine Department, Medical University of Warsaw, Warsaw, Poland.
authors.forename: Joanna
authors.initials: J
authors.lastname: Niesiobędzka-Krężel
authors.affiliation: Hematology Department, Teaching Hospital No 1 in Rzeszów, Rzeszów, Poland.
authors.forename: Marek
authors.initials: M
authors.lastname: Dudziński
authors.affiliation: Hematology Department, Medical University of Białystok, Białystok, Poland.
authors.forename: Ewa
authors.initials: E
authors.lastname: Wasilewska
authors.affiliation: Hematology Department, Clinical Hospital in Zielona Góra, Zielona Góra, Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Myśliwiec
authors.affiliation: Department of Hematology, Markiewicz Memorial Oncology Center Brzozow, Brzozow, Poland.
authors.forename: Justyna
authors.initials: J
authors.lastname: Gil
authors.affiliation: Hematology Department, Medical University in Poznań, Poznań, Poland.
authors.forename: Michał
authors.identifier: http://orcid.org/0000-0002-7535-3316
authors.initials: M
authors.lastname: Gniot
authors.affiliation: Hematology and Internal Medicine Department, Rydygier Specialistic Hospital, Kraków, Poland.
authors.forename: Iwona
authors.initials: I
authors.lastname: Pietkun
authors.affiliation: Department of Hematology, Neoplastic Blood Disorders and Bone Marrow Transplantation in Wrocław, Poland.
authors.forename: Ewa
authors.initials: E
authors.lastname: Mędraś
authors.affiliation: Department of Hematology, Specialized Hospital in Legnica, Poland.
authors.forename: Jadwiga
authors.initials: J
authors.lastname: Hołojda
authors.affiliation: Chair and Department of Hematology, Jagiellonian University Medical College, Kraków, Poland.
authors.forename: Joanna
authors.initials: J
authors.lastname: Wącław
authors.affiliation: Experimental Hematooncology Department, University of Lublin, Lublin, Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Giannopoulos
mesh_terms: D000328:Adult; D000368:Aged; D016568:Drugs, Generic / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate / Q000008:administration & dosage* / Q000009:adverse effects; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011044:Poland
chemical_list: D016568:Drugs, Generic; D000068877:Imatinib Mesylate